Author

Hongxing Wan

Observed names: H. Wan, Wan, Hongxing

Institution: Sanya Central Hospital

Observed institution: Sanya Central Hospital

ORCID: 0000-0002-3873-1736

Observed ORCID: 0000-0002-3873-1736

OpenAlex ID: A5011768324

Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy

2016 · Zhiqiang Li, Yang Sun, et al. · Oncotarget · 46

ST8SIA1 inhibition sensitizes triple negative breast cancer to chemotherapy via suppressing Wnt/β-catenin and FAK/Akt/mTOR

2020 · H. Wan, Z. Li, et al. · Clinical & Translational Oncology · 36

Comparing ChatGPT's and Surgeon's Responses to Thyroid-related Questions From Patients

2024 · Siyin Guo, Ruicen Li, et al. · The Journal of Clinical Endocrinology & Metabolism · 24

Blockage of cytosolic phospholipase A2 alpha sensitizes aggressive breast cancer to doxorubicin through suppressing ERK and mTOR kinases

2018 · Zhiqiang Li, Miao Qu, et al. · Biochemical and Biophysical Research Communications · 21

Recurrence-Associated Long Non-coding RNA LNAPPCC Facilitates Colon Cancer Progression via Forming a Positive Feedback Loop with PCDH7

2020 · Ting Li, Zhiqiang Li, et al. · Molecular Therapy — Nucleic Acids · 12

[Overexpression of N-myc downstream regulated gene 2 (NDRG2) inhibits proliferation, migration and promotes apoptosis in SW480 rectal cancer cells].

2017 · Zhiqiang Li, Yang Sun, et al. · PubMed · 2

Factors associated with the transition of nutrition status in adults with cancer during radiotherapy

2023 · H. Wan · Clinical Nutrition ESPEN

Works count: 8

Citation count: 142

H-index: 5

I10-index: 5